Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Tech Gazette.
Press releases published on May 7, 2025
Kymera Therapeutics to Participate in Fireside Chat at the BofA Securities 2025 Health Care Conference
GlobeNewswire
·
May 7, 2025
WATERTOWN, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the …
Lyra Therapeutics to Present 52-week Extension Stage Results for ENLIGHTEN 1 Phase 3 Study for LYR-210 for the Treatment of Chronic Rhinosinusitis at COSM 2025
GlobeNewswire
·
May 7, 2025
Results from ENLIGHTEN 1 Phase 3 Extension Stage support LYR-210’s favorable safety profile and general consistency with the Primary Study Phase in patients with CRS In the CRS patient subgroup with nasal polyps, analysis showed improvements in both …
Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
Generated $166.8 million in 1Q 2025 revenues, including $149.9 million in U.S. net product sales SYFOVRE® (pegcetacoplan injection) injection demand grew 4% quarter-over-quarter, with U.S. net product revenue of $130.2 million Increase in demand offset by …
Lirum Therapeutics Announces New LX-101 Data in Thyroid Eye Disease Selected for Presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting
GlobeNewswire
·
May 7, 2025
New York, NY, May 07, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today that new results with LX-101 in Thyroid Eye Disease …
Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City
GlobeNewswire
·
May 7, 2025
TEL AVIV, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will host Innovation …
Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved
GlobeNewswire
·
May 7, 2025
For an accessible version of this Press Release, please visit www.tevapharm.com On track for 30% operating profit margin by 2027 in line with our Pivot to Growth Strategy; Q1 2025 shows ninth consecutive quarter of revenue growth, excluding revenues …
Climb Channel Solutions Partners with Smartsheet for Industry-Leading Collaborative Work Management
GlobeNewswire
·
May 7, 2025
EATONTOWN, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) is excited to be adding Smartsheet, the AI-enhanced …
Atea Pharmaceuticals Announces Full Results from Phase 2 Study of Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus (HCV) Presented at EASL Congress 2025
GlobeNewswire
·
May 7, 2025
Full Results from Phase 2 Study Confirmed 98% Sustained Virologic Response at 12 Weeks Post-Treatment (SVR12) After Short 8-Week Treatment Duration for Regimen Results from Phase 1 Study Showed Low Risk for Drug-Drug Interactions with Regimen When …
Amicus Therapeutics to Present at the Bank of America 2025 Health Care Conference
GlobeNewswire
·
May 7, 2025
PRINCETON, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Bank of America 2025 Health Care Conference in Las Vegas, NV on Wednesday, May 14, 2025, at 8:00 …
Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance
GlobeNewswire
·
May 7, 2025
-- Generated $52.5 million in net revenue from sales of LUMRYZ™, a 93% increase over the first quarter of 2024 -- -- 2,800 patients on LUMRYZ as of March 31, 2025, a net increase of 300 patients since December 31, 2024 and a 100% year over year increase …
Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 7, 2025
Worldwide revenue of $372.8 million in the first quarter 2025 GAAP fully diluted earnings per share of $1.02, compared to $1.87 in the first quarter of 2024; adjusted fully diluted earnings per share of $1.53, compared to $1.69 in the first quarter of 2024 …
EyePoint Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Developments
GlobeNewswire
·
May 7, 2025
– Enrollment continues to exceed expectations in DURAVYU™ Phase 3 wet AMD clinical trials with over 90% of patients randomized into the LUGANO trial and over 50% into the LUCIA trial, reinforcing confidence in enrollment completion in 2H 2025 and expected …
Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting
GlobeNewswire
·
May 7, 2025
Codexis to showcase data that demonstrate the scalability and reproducibility of its enzymatic siRNA manufacturing processes Three CDMO presentations to feature data on performance of Codexis double-stranded RNA ligases Management will host a conference …
Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update
GlobeNewswire
·
May 7, 2025
-- First quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $37.7 million -- -- Setmelanotide pivotal Phase 3 TRANSCEND trial met primary endpoint with -19.8% placebo-adjusted BMI reduction in patients (N=120) with acquired …
Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025
GlobeNewswire
·
May 7, 2025
SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will host a conference call on …
XRP News Today: CME to Launch XRP Futures on May 19 — StratoVM Surges 2,939% as Analysts Eye $10 XRP Target This Summer
GlobeNewswire
·
May 7, 2025
ROAD TOWN, British Virgin Islands, May 07, 2025 (GLOBE NEWSWIRE) -- XRP News Today – Ripple is making headlines once again as CME Group gears up to launch XRP futures on May 19, signaling a potential surge in institutional interest. Combined with improving …
Compliance First: OFUYC Releases In-Depth Stablecoin Audit Solution
GlobeNewswire
·
May 7, 2025
GREENWOOD VILLAGE, Colo., May 07, 2025 (GLOBE NEWSWIRE) -- The digital currency market is undergoing regulatory consolidation, with stablecoin compliance becoming a key focus. To address global requirements for reserve auditing, transparency, and anti- …
Earn Passive Income: ALR Miner Noted As Most Profitable Cloud Mining Apps of 2025
GlobeNewswire
·
May 7, 2025
Monmouth, Monmouthshire, May 07, 2025 (GLOBE NEWSWIRE) -- Tired of chasing fast money and high-risk cryptocurrency trading? How great would it be if you could easily earn real money every day? Welcome to ALR Miner—your golden ticket to earning passive …
e-Commerce B2B : ne pas se laisser distancer par la concurrence
GlobeNewswire
·
May 7, 2025
Dans l’univers B2B, il est courant d’apprendre par hasard qu’un concurrent a lancé un site e-commerce ou une plateforme de vente digitale pour développer ses ventes. Contrairement au B2C, ce genre d’initiative reste souvent invisible… jusqu’à ce que les …
Panasonic TOUGHBOOK Expands European Service and Solutions Capabilities
GlobeNewswire
·
May 7, 2025
New investment in Cardiff and Budapest centres strengthens Panasonic’s commitment to full lifecycle support - from solution design and deployment to real-time servicing and innovation at the edge. Wiesbaden, DE. 7th May 2025 – As mobile workforces across …